ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AGFX Argentex Group Plc

36.20
0.65 (1.83%)
20 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argentex Group Plc LSE:AGFX London Ordinary Share GB00BJLPH056 ORD �0.0001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.65 1.83% 36.20 35.50 36.90 37.00 36.20 36.90 650,414 16:16:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Security,commodity Exchanges 49.9M 5.1M 0.0423 8.56 42.81M
Argentex Group Plc is listed in the Security,commodity Exchanges sector of the London Stock Exchange with ticker AGFX. The last closing price for Argentex was 35.55p. Over the last year, Argentex shares have traded in a share price range of 26.00p to 77.00p.

Argentex currently has 120,429,055 shares in issue. The market capitalisation of Argentex is £42.81 million. Argentex has a price to earnings ratio (PE ratio) of 8.56.

Argentex Share Discussion Threads

Showing 1676 to 1699 of 2425 messages
Chat Pages: Latest  73  72  71  70  69  68  67  66  65  64  63  62  Older
DateSubjectAuthorDiscuss
07/7/2022
15:40
The reason for the change is the imbalance caused by higher Q4 sales which falls in the 2H, after the change the imbalance remains but is just reversed to the 1H - so the rationale certainly seems BS.
trident5
07/7/2022
15:25
Is it just me or does anyone feel like they are diguising profits are going to be lower hence the they change the year end?

Just to be clear I can see sales are forecast up but profits are lower as they are increasing cost base investment in technology etc

sebass
07/7/2022
15:21
Both are listed on the website as members of the Executive Committee (of the LLP)
rik shaw
07/7/2022
14:01
His LinkedIn is still as Argentex and the company would have had to RNS such a departure.I have no answer for you regards to the webby!
manics
07/7/2022
13:51
CCO and founder Andrew Egan has left the business it seems. Partner Daniel Merrick too. Neither of them are on the website anymore.
stoney montana
07/7/2022
08:11
There are a large number of shares ready to be sold when it (ever) gets above 80p and this will I think keep the price depressed. Remember Carl sold 12m shares at 80p and Amati appear to want out.

I think this one is about timing.

toffeeman
07/7/2022
07:22
Exactly, the market doesn't lie this company for some reason - but does like its competition.
trident5
07/7/2022
06:41
Confident presentation on IMC from the CEO (and CFO, COO)- said he was adamant they don’t fall into a pattern of missing growth expectations and described forecasts as “conservative”

Record numbers, good start to the new year, low rating, cash rich, decent yield, expansion plans, directors holding decent stakes- strange reaction re yesterday’s numbers

se81
06/7/2022
18:30
https://www.investorschronicle.co.uk/news/2022/07/06/argentex-open-to-trade/
tole
06/7/2022
17:26
"compared with its peer JIM Jarvis Securities...." ???

Try AFX and EQLS.

valhamos
06/7/2022
16:57
https://www.fool.co.uk/2022/07/06/a-ftse-aim-stock-id-add-to-my-stocks-shares-isa-in-july/A FTSE AIM stock I'd add to my Stocks & Shares ISA in JulyHenry Adefope highlights a FTSE AIM stock he believes could generate significant upside for his portfolio if he buys this monthOne such company is specialist foreign exchange provider Argentex (LSE:AGFX), an AIM stock that I believe can provide me with high growth potential at a cheap price.A penny stock with capital growth potentialThe company is a simple business for modern times. It helps businesses and wealthy individuals handle their foreign exchange requirements. It is a disrupter aiming to take market share away from the banks by offering a better, cheaper service. This represents fertile ground for sustained growth.It has grown its revenue and profit every year since it floated a decade ago, demonstrating resilience and sustainability. Even during times of economic turmoil like the pandemic its customer demand remained consistent.Not only is the company profitable, it is also debt-free with £23m of net cash at the end of September 2021. In addition, Argentex continues to expand internationally despite the choppy market environment. The strategy appears to be working. Client numbers increased by 20% year on year according to its most recent trading update.Analysts expect earnings to grow more than 35% this year and the next. Yet, despite the ambitious forecasts, the shares trade on a multiple of just 11 times. This looks cheap to me compared with its peer, JIM Jarvis Securities, which trades on a multiple of 16 times.Are the shares trading below fair value?Just a year ago, Argentex shares were trading at around 125p, but they have since fallen to under 80p. I am surprised the stock has fallen out of favour with investors. It seems an unfair price for a company with continued profit margin and revenue growth.Oct '21Jan '22Apr '22Jul '22Jul '22708090100Zoom ?Jul 6, 2021?Jul 5, 2022Highcharts.comEven City analysts believe the stock is currently trading at 40% below fair value, with the view that a price of £1.32 better reflects the stock's prospects. I am inclined to agree.My ISA portfolio is relatively volatile currently, and there seems no end to this anytime soon. The knock-on effect of this volatility has been a rather brutal decline to my fund value. Many of the large-cap technology growth stocks that generated the greatest capital returns in my portfolio in the recent past have been some of my worst performers this year.I have had to look further afield for the prospect of growth, and Argentex is just one example of an AIM company with incredible growth prospects and a modest price.Based on its stellar future prospects, the shares have the potential to double in price over the next year alone. This is why I may buy this month before I miss the dip.
tole
06/7/2022
13:29
Not all that cash is theirs though.
trident5
06/7/2022
12:08
Has c30p per share cash, EPS 7p. Showing decent growth too. I know they’ve disappointed in the past, but seems undervalued to me. Not buying anything at the moment but it’s back on the watchlist
dr biotech
06/7/2022
11:18
Investor meet company at 16:00- submit your questions!
se81
06/7/2022
08:26
It says 12 months. FY revs 39mm with EBITDA 9.9mm and PBT 7.0mm.
wjccghcc
06/7/2022
08:20
Only 9 months worth?
bunlop
06/7/2022
08:16
For y/e 12/22 they forecast 4.9p. I guess it's the increased investment?
wjccghcc
06/7/2022
08:12
Can anyone reconcile their comment: "Spot/forward revenue mix remains balanced (Forward 51%, Spot 49%) with Note 5 which gives:
Spot revenue of £6.4m and Forward revenue of £27.2m. ?

trident5
06/7/2022
07:49
so Singers think we go from 6.4p for the 12m ended March 2022, to 6.4p for the 12m ended December 2023?

Asagi (long AGFX)

asagi
06/7/2022
07:42
Singers initiate with 12/23 EPS of 6.4p.
wjccghcc
06/7/2022
06:50
Yes solid results with increasing revenue and EPS.
Presentation this afternoon on InvestorMeetCompany at 4pm.

rik shaw
06/7/2022
06:39
good update cant detect ant problems
ali47fish
13/6/2022
17:01
Relative strength here in these dire mkts (a welcome change for AGFX)
se81
31/5/2022
16:02
ali47fish- retail via investor meet company, 6th July 16:00
se81
Chat Pages: Latest  73  72  71  70  69  68  67  66  65  64  63  62  Older

Your Recent History

Delayed Upgrade Clock